Literature DB >> 19782933

Venous and arterial thrombosis: two aspects of the same disease?

Paolo Prandoni.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19782933     DOI： 10.1016/j.ejim.2009.02.001

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN： 0953-6205            Impact factor:   4.487


× No keyword cloud information.
  12 in total

1.  Genome-wide association analysis of self-reported events in 6135 individuals and 252 827 controls identifies 8 loci associated with thrombosis.

Authors:  David A Hinds; Alfonso Buil; Daniel Ziemek; Angel Martinez-Perez; Rainer Malik; Lasse Folkersen; Marine Germain; Anders Mälarstig; Andrew Brown; Jose Manuel Soria; Martin Dichgans; Nan Bing; Anders Franco-Cereceda; Juan Carlos Souto; Emmanouil T Dermitzakis; Anders Hamsten; Bradford B Worrall; Joyce Y Tung; Maria Sabater-Lleal
Journal:  Hum Mol Genet       Date:  2016-02-09       Impact factor: 6.150

Review 2.  Factor IX(a) inhibitors: an updated patent review (2003-present).

Authors:  Daniel K Afosah; Edward Ofori; Madhusoodanan Mottamal; Rami A Al-Horani
Journal:  Expert Opin Ther Pat       Date:  2022-01-17       Impact factor: 6.674

3.  Epidemiology of venous thromboembolism in the Framingham Heart Study.

Authors:  Marja K Puurunen; Philimon N Gona; Martin G Larson; Joanne M Murabito; Jared W Magnani; Christopher J O'Donnell
Journal:  Thromb Res       Date:  2016-06-29       Impact factor: 3.944

4.  VE-1902-A direct thrombin inhibitor with reversible covalent mechanism of action shows efficacy with reduced bleeding in rodent models of thrombosis.

Authors:  Mohanram Sivaraja; Daniel M Clemens; Sivan Sizikov; Subhadra Dash; Chengpei Xu; Matthew Rienzo; Bo Yang; Molly Ryan; Madhuri Chattopadhyay; Lev Igoudin; Stephanie S Chang; Samuel Keutzer; Piotr Zalicki; M Angels Estiarte; Timothy P Shiau; Kevin M Short; David C Williams; Anirban Datta; Nicola Pozzi; Enrico Di Cera; C Michael Gibson; Keith A A Fox; David B Kita
Journal:  Thromb Res       Date:  2020-04-19       Impact factor: 3.944

5.  Comparison of pathological clotting using haematological, functional and morphological investigations in HIV-positive and HIV-negative patients with deep vein thrombosis.

Authors:  Brandon S Jackson; Julien Nunes Goncalves; Etheresia Pretorius
Journal:  Retrovirology       Date:  2020-06-22       Impact factor: 4.602

6.  Association of apolipoproteins C-I, C-II, C-III and E with coagulation markers and venous thromboembolism risk.

Authors:  Fernanda A Orsi; Willem M Lijfering; Arnoud Van der Laarse; L Renee Ruhaak; Frits R Rosendaal; Suzanne C Cannegieter; Christa Cobbaert
Journal:  Clin Epidemiol       Date:  2019-07-22       Impact factor: 4.790

7.  Individualized predictions of early isolated distal deep vein thrombosis in patients with acute ischemic stroke: a retrospective study.

Authors:  Hao-Ran Cheng; Gui-Qian Huang; Zi-Qian Wu; Yue-Min Wu; Gang-Qiang Lin; Jia-Ying Song; Yun-Tao Liu; Xiao-Qian Luan; Zheng-Zhong Yuan; Wen-Zong Zhu; Jin-Cai He; Zhen Wang
Journal:  BMC Geriatr       Date:  2021-02-25       Impact factor: 3.921

8.  Intracranial Major Artery and Venous Sinus Thrombosis in a Young Male with MTHFR Mutation and Protein S Deficiency.

Authors:  Dhanashree Peddawad
Journal:  Case Rep Neurol       Date:  2021-11-18

Review 9.  Current use of rivaroxaban in elderly patients with venous thromboembolism (VTE).

Authors:  Xin Zhang; Qiyan Cai; Xiaohui Wang; Ke Liao; Changchun Hu; Hong Chen
Journal:  J Thromb Thrombolysis       Date:  2021-03-05       Impact factor: 2.300

10.  Comprehensive platelet phenotyping supports the role of platelets in the pathogenesis of acute venous thromboembolism - results from clinical observation studies.

Authors:  Marina Panova-Noeva; Bianca Wagner; Markus Nagler; Thomas Koeck; Vincent Ten Cate; Jürgen H Prochaska; Stefan Heitmeier; Imke Meyer; Christoph Gerdes; Volker Laux; Stavros Konstantinides; Henri M Spronk; Thomas Münzel; Karl J Lackner; Kirsten Leineweber; Hugo Ten Cate; Philipp S Wild
Journal:  EBioMedicine       Date:  2020-09-10       Impact factor: 8.143
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.